Veradermics Inc <MANE.N>: B. Riley initiates coverage with buy rating; target price $170
MANE•Related News
Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
CLSD•
AJB Investment Fund II acquires $29,746.58 of Jewett-Cameron Trading common shares
JCTC•
Brightstar Lottery publishes 2025 sustainability report
BRSL•
JPMorgan <JPM.N>: Jefferies raises target price to $350 from $340
JPM•
Big Blue's bad day raises the bar for ASML
ASML•